EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms and clinical implications of gut-brain interactions

Zachary S Lorsch, Rodger A Liddle

Journal of Clinical Investigation · 02.01.2026 · 136 (1)

DOI: 10.1172/jci196346 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.01.2026. Verfasst von Zachary S Lorsch und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and. Hauptthemen laut MEDLINE: Brain, Gastrointestinal Microbiome, Brain-Gut Axis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Connections between the digestive system and the brain have been postulated for over 2000 years. Despite this, only recently have specific mechanisms of gut-brain interaction been identified. Due in large part to increased interest in the microbiome, the wide use of incretin-based therapies (i.e., glucagon-like peptide 1 [GLP-1] receptor agonists), technological advancements, increased understanding of neuroimmunology, and the identification of a direct enteroendocrine cell–neural circuit, research in the past 10 years has made it abundantly clear that the gut-brain connection plays a role both in clinical disease as well as the actions of therapeutics. In this Review, we describe mechanisms by which the gut and brain communicate and highlight human and animal studies that implicate changes in gut-brain communication in disease states in gastroenterology, neurology, psychiatry, and endocrinology. Furthermore, we define how GLP-1 receptor agonists for obesity and guanylyl cyclase C agonists for irritable bowel syndrome leverage gut-brain mechanisms to improve patient outcomes. This Review illustrates the critical nature of gut-brain communication in human disease and the potential to target gut-brain pathways for therapeutic benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainGastrointestinal MicrobiomeBrain-Gut AxisHumansAnimalsGlucagon-Like Peptide-1 ReceptorObesityIrritable Bowel SyndromeGlucagon-Like Peptide-1 Receptor Agonists

Substanzen

Glucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Medicine and.
  • Duke Institute for Brain Sciences, Duke University, Durham, North Carolina, USA.
  • Department of Veterans Affairs Healthcare System, Durham, North Carolina, USA.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Lorsch, Z. S., & Liddle, R. A. (2026). Mechanisms and clinical implications of gut-brain interactions. Journal of Clinical Investigation, 136(1). https://doi.org/10.1172/jci196346

Vancouver

Lorsch ZS, Liddle RA. Mechanisms and clinical implications of gut-brain interactions. Journal of Clinical Investigation. 2026;136(1). doi:10.1172/jci196346

BibTeX
@article{Lorsch2026,
  author = {Lorsch, Zachary S and Liddle, Rodger A},
  title = {Mechanisms and clinical implications of gut-brain interactions},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {1},
  doi = {10.1172/jci196346}
}
Kostenlos starten →